Joseph Sparano

49PUBLICATIONS
311CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsMolecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Jul 17, 2026
Development and Validation of a Multimodal-Multitask Deep Learning Approach for Estimating Late Distant Recurrence Risk in HR-Positive Early Breast Cancer.

|Mar 10, 2026
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease.

Natasha B Hunter, Heather A Parsons, Leslie Cope

|Nov 10, 2025
Machine Learning-Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2- Early Breast Cancer Using Real-World and NATALEE Data.

Frederick M Howard, Peter A Fasching, Cesar A Santa-Maria

|Nov 10, 2025
A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast Cancer.

Keith L Knutson, Hala Abu-Fares, Patricia Keating

|Feb 27, 2025
Impact of race/ethnicity on MammaPrint genomic assay risk and prognosis in early breast cancer: A National Cancer Data Base analysis.

Rima B Patel, Tianxiang Sheng, Marcio A Diniz

|Jan 21, 2025
Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2- Breast Cancer.

Rahat Alam, Anna Reva, David G Edwards

Pageof 9

Frequent Collaborators

10 joint publications

Antonio C Wolff

8 joint publications

Lynne I Wagner

6 joint publications

Robert J Gray

5 joint publications

Sofia F Garcia